CLINICAL OUTCOME AND IMMUNOLOGY OF POSTOPERATIVE ARGININE, OMEGA-3-FATTY-ACIDS, AND NUCLEOTIDE-ENRICHED ENTERAL FEEDING - A RANDOMIZED PROSPECTIVE COMPARISON WITH STANDARD ENTERAL AND LOW-CALORIE LOW-FAT IV SOLUTIONS
J. Schilling et al., CLINICAL OUTCOME AND IMMUNOLOGY OF POSTOPERATIVE ARGININE, OMEGA-3-FATTY-ACIDS, AND NUCLEOTIDE-ENRICHED ENTERAL FEEDING - A RANDOMIZED PROSPECTIVE COMPARISON WITH STANDARD ENTERAL AND LOW-CALORIE LOW-FAT IV SOLUTIONS, Nutrition, 12(6), 1996, pp. 423-429
In a prospective randomized trial in patients undergoing major abdomin
al surgery, the impact of a new enteral formula supplemented with argi
nine, omega-3 fatty acids, and nucleotides (A, n = 14) on immunologica
l parameters was compared with a standard enteral formula (B, n = 14)
and a low calorie/low fat intravenous solution (C, n = 13). Four days
postoperatively, a statistically significant decrease in total leukocy
te count (A, 9.0 +/- 2.9; B, 8.0 +/- 2.4; C, 11.1 +/- 3.5 x 10(6) cell
s/mL; A versus C, B versus C; p < 0.05), higher percentage of lymphocy
tes (A, 14.3 +/- 4.9; C, 8.2 +/- 6.1; p < 0.05), and decreased median
CRP levels (A, 80.4 [69.9]; B, 70 [74]; C, 88.5 [142] in mg/L; A versu
s C, p < 0.05; B versus C; p < 0.05) were observed in the enteral nutr
ition groups. The expression of activated surface antigen HLA-DR was d
iminished on CD14(+) cells over 4 d (A, 58.2 [39.2]; B, 52.2 [36.2]; C
, 76.6 [25.2] in %; A versus C, p < 0.05; B versus C, p < 0.05) and 8-
10 d (A, 37.9 [31.4]; C, 58.5 [37.6]; p < 0.05) postoperatively. Signi
ficantly enhanced median phagocytic activity of CD14(+) monocytes and
granulocytes was observed in group C 8-10 days postoperatively (A, 83.
3 [11.8];B, 71.6 [34.1]; C, 87.4 [10.8]; A versus B, B versus C, p < 0
.05; and A, 75.7 [10.0]; B, 69.0 [37.8]; C, 80.0 [10.1] in %, B versus
C, p < 0.05, respectively). Postoperative hospital and intensive care
unit stay was similar among the three groups; however, infectious com
plications were less frequent in group A (A versus C, p = 0.15). Thus,
a modified enteral nutritional support and supplementation may influe
nce the immune competence toward a more efficient defense response.